PHOENIX, May 15, 2025 (GLOBE NEWSWIRE) -- QuoteMedia, Inc. (OTCQB: QMCI), a leading provider of market data and financial applications, announced financial results for the quarter ended March 31, 2025. QuoteMedia provides banks, brokerage firms, private equity firms, financial planners and sophisticated investors with a more economical, higher quality alternative source of stock market data and related research information. We compete with several larger legacy organizations and a modest community of other ...

公司业绩表现 - 2025年第一季度总营收为7214万美元，同比下降5%，其中物联网连接业务收入5391万美元占比75%，物联网解决方案收入1822万美元占比25% [6] - 运营现金流同比增长51%至290万美元，连续第二个季度实现正现金流 [8] - 自由现金流同比增长121%至60万美元，同样连续第二个季度为正 [8] - 运营费用同比下降15%至4160万美元，主要由于2024年8月宣布的重组措施 [8] 运营指标 - 期末总连接数达到1980万，同比增长8% [6][8] - 平均每用户收入(ARPU)为0.91美元，低于去年同期的1.05美元 [6] - 美元净扩张率(DBNER)提升至99%，去年同期为94% [6] - 物联网解决方案毛利率提升210个基点至33%，非GAAP毛利率提升370个基点至39.9% [8] 业务发展 - 公司即将突破2000万总连接数的重要里程碑 [3] - 新增多个重要客户，预计新连接将逐步转化为连接收入 [3] - 扩展了间接渠道合作伙伴关系，推动盈利增长 [4] 财务展望 - 维持2025年全年收入预期2.88-2.98亿美元 [9] - 预计调整后EBITDA为6200-6700万美元 [9] - 预计自由现金流为1000-1400万美元 [9] 行业与业务模式 - 作为全球纯物联网超大规模服务商，提供物联网连接、解决方案和分析服务 [1] - 通过eSIM技术管理连接数，但不包括运营商许可平台的部分连接 [20] - 采用DBNER指标衡量现有客户交叉销售、留存和业务增长情况 [22][26] - 使用ARPU指标评估每个连接产生的收入表现 [28]

EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin1 Improved (9)%, a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions Inc. (NYSE American: SRXH) (the “Company” or "SRx", previously known as “Better Choice”), a leading global health and wellness company, today announced its results for the first quarter ended March 31, 2025. "We have executed a digital first strategy ...

文章核心观点 公司2025财年第三季度及前九个月财务和运营成果良好，业务发展态势积极，通过战略举措和运营优化实现了盈利增长和财务状况改善，未来有望持续发展并为股东创造价值 [4][7][11] 公司业务亮点 - 与派拉蒙影业达成独家家庭娱乐许可协议，成为其美加地区实体媒体独家被许可方 [6] - 收购后扩大Handmade by Robots零售分销，借助零售网络推出独家授权收藏品，2025年下半年将有重要新作品发布 [6] - 实体电影销售同比增长39%，从4200万美元增至5800万美元，黑胶唱片销售同比增长11%，从7800万美元增至8600万美元 [6] - 高利润率的消费者直接履约（CDF）销售占总销售营收的35%，高于2024财年第三季度的33% [6][10] - 库存水平降至9320万美元，较2024年3月31日的1.08亿美元下降13%，营运资金降至4630万美元，较2024年3月31日的5730万美元减少 [6] - 总运营费用同比降低11.4%，分销和履约成本因自动化举措和仓库运营整合下降10.2%，利息费用同比下降20.2% [6] 财务结果 第三季度（2025年3月31日止） - 净收入2.13亿美元，同比增长1% [15] - 毛利润2910万美元，同比增长3.7%，毛利率从13.2%提升至13.6% [15] - 净利润190万美元，去年同期净亏损340万美元 [15] - 调整后EBITDA为490万美元，同比增长66% [15] 前九个月（2025年3月31日止） - 净收入8.357亿美元，去年同期为8.635亿美元 [15] - 毛利润9690万美元，去年同期为1.02亿美元，毛利率为11.6%，去年同期为11.8% [15] - 净利润930万美元，同比增长349% [15] - 调整后EBITDA为2440万美元，同比增长9.9% [15] 公司概况 - 是娱乐和流行文化收藏品行业的主要分销商和履约合作伙伴，拥有超32.5万个独特库存SKU，服务超3.5万个零售点 [18] - 凭借运营专长、独家许可合作和轻资产可扩展基础设施，成为全球顶级娱乐品牌和零售商的可靠合作伙伴 [18]

ImmuCell (ICCC) Q1 2025 Earnings Call May 15, 2025 09:00 AM ET Company Participants Joe Diaz - Managing PartnerMichael Brigham - President, CEO & DirectorTimothy Fiori - CFOGeorge Melas-Kyriazi - PresidentRussell Tolander - Managing Director Conference Call Participants None - Analyst Operator Good morning, and welcome to the Innucel Corporation report First Quarter Ended 03/31/2025 Audited Financial Results Conference Call. All participants will be in listen only mode. After today's presentation, there wil ...

PLAINVIEW, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services, and proprietary medical products, today announced its operating results for the three months ended March 31, 2025. “The Company recorded record first quarter revenue, with revenue of $19.5 million, an increase of 3.9% when compared to the same quarter of the prior year,” commented Dr. Jun ...

Record Bookings of $23.1M, Strong SaaS ARR Growth at 15% Q1 2025 Highlights | Revenue (in $ millions) | | | | | | | --- | --- | --- | --- | --- | --- | | SaaS Subscription | | Recurring | | Total | | | Reported | Y/Y growth | Reported | Y/Y growth | Reported | Y/Y growth | | $7.8 | 15% | $10.9 | 6% | $16.3 | 3% | CALGARY, Alberta, May 15, 2025 (GLOBE NEWSWIRE) -- Sylogist Ltd. (TSX: SYZ) ("Sylogist" or the "Company"), a leading public sector SaaS company, today announced its results for the first quarter fi ...

| | Three Months Ended March 31, | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 2025 | | | 2024 | | | Change | | | | | | % of | | | | % of | | | | | | | (in thousands, except percentages) | | $ | Total | $ | Total | | $ | | % | | | Revenues by product: | | | | | | | | | | | | Venus Prime / Subscription—Systems | $ $ | 2,649 | 19.4 | 3,531 | | 20.2 $ | (882 | ) | (25.0 | ) | Total revenue for the first quarter of $13.6 million, down 22% year-over-year, reflecting ...

业绩总结 - 2025年第一季度总收入为11亿美元，同比增长14.1%（以固定汇率计算）[13] - 同期可比销售增长11.1%，与该期间的综合通胀率持平[17] - 调整后EBITDA为9130万美元，EBITDA利润率为8.5%[13] - 净收入为1390万美元，每股收益为0.07美元[13] - 2025年第一季度净收入为28509万美元，净收入率为1.3%[94] - 2025年第一季度调整后EBITDA为108935万美元，占总收入的10.1%[99] 用户数据 - 数字销售同比增长6.3%，在美国市场表现强劲[16] - 巴西市场的可比销售增长为2.9%，尽管面临更严格的比较[24] - 南拉美地区（SLAD）可比销售增长达到39.1%[33] - 公司在六个市场推出了忠诚度计划，注册会员达到1880万[62] 资本支出与财务状况 - 2025年第一季度的资本支出为4880万美元，其中2140万美元用于增长[75] - 2025年第一季度的总债务为1163百万美元，现金及现金等价物为495百万美元，净债务为668百万美元[96] - 2025年第一季度的杠杆比率为5.0倍[96] 其他财务信息 - 2025年第一季度的外汇损益为998万美元[99] - 2025年第一季度的利息支出和其他融资结果为16438万美元[99] - 2025年第一季度的折旧和摊销费用为43091万美元[99] - 2025年第一季度的税费支出为18961万美元[99] - 2025年第一季度的非控股权益净收入为283万美元[99] 新开餐厅 - 12家新餐厅开业，其中包括10家独立餐厅[13]

The Oncology Institute (TOI) Q1 2025 Earnings Call May 14, 2025 05:00 PM ET Speaker0 Good afternoon, and welcome to the Oncology Institute's First Quarter twenty twenty five Earnings Conference Call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q and A. At this time, I'd like to turn the conference over to Mark Heplheiser, General Counsel at TOI. Thank you. You may begin. Speaker1 The press release announcing the Oncology Institute's results for the first quarter o ...